Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,131 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL

NCT05478512

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Ematologia AOU Careggi Florence, Italy
  • Ematologia IRST D.Amadori Meldola, Italy
  • Ematologia AO di Perugia Perugia, Italy
  • Ematologia Ospedale S.M. delle Croci Ravenna, Italy
View Trial Details
Active, not recruiting

Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma

NCT06353022

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CH de la Côte Basque Bayonne, France
  • CHU Caen Caen, France
  • CHRU DIjon Dijon, France
  • Chd Vendee La Roche-sur-Yon, France
View all 19 locations
View Trial Details
Active, not recruiting

A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)

NCT05624554

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Highlands Oncology Group ( Site 5205) Springdale, Arkansas, United States
  • Clermont Oncology Center ( Site 5224) Clermont, Florida, United States
  • Hattiesburg Clinic Hematology/Oncology ( Site 5216) Hattiesburg, Mississippi, United States
  • Medical Oncology Associates, PS ( Site 5206) Spokane, Washington, United States
View all 97 locations
View Trial Details
Active, not recruiting

Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma

NCT05783596

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Irving Medical Center New York, United States
  • Mount Sinai Medical Center New York, United States
View Trial Details
Active, not recruiting

Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia

NCT05524077

Conditions
Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +30 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Nepean Hospital Kingswood, New South Wales, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Royal North Shore Hospital Saint Leonards, New South Wales, Australia
View Trial Details
Active, not recruiting

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

NCT03336333

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Augusta University Augusta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Research Medical Center Kansas City, Missouri, United States
View all 158 locations
View Trial Details
Active, not recruiting

Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD

NCT06636487

Conditions
Asthma Bronchiale, Bronchial Diseases, Bronchiectasis, +14 more
Locations
  • Copenhagen University Center, Amager Copenhagen, Greater Copenhagen, Denmark
  • Copenhagen University Center, Frederiksberg-Bispebjerg Copenhagen, Greater Copenhagen, Denmark
  • Copenhagen University Center, Hvidovre Copenhagen, Greater Copenhagen, Denmark
  • Copenhagen University Center, Herlev-Gentofte Gentofte Municipality, Greater Copenhagen, Denmark
View Trial Details

Related conditions